Chaumette Boris, Kebir Oussama, Mam-Lam-Fook Célia, Morvan Yannick, Bourgin Julie, Godsil Bill P, Plaze Marion, Gaillard Raphaël, Jay Thérèse M, Krebs Marie-Odile
Centre Hospitalier Sainte-Anne, Service Hospitalo-Universitaire-S14, Faculté de Médecine Paris Descartes, 75014 Paris, France; Université Paris Descartes, Sorbonne Paris Cité, 75006 Paris, France; INSERM UMR 894, Centre de Psychiatrie et Neurosciences, Laboratoire de Physiopathologie des Maladies Psychiatriques, Institut de Psychiatrie-GDR 3557 de Psychiatrie, 75014 Paris, France.
Centre Hospitalier Sainte-Anne, Service Hospitalo-Universitaire-S14, Faculté de Médecine Paris Descartes, 75014 Paris, France; INSERM UMR 894, Centre de Psychiatrie et Neurosciences, Laboratoire de Physiopathologie des Maladies Psychiatriques, Institut de Psychiatrie-GDR 3557 de Psychiatrie, 75014 Paris, France.
Psychoneuroendocrinology. 2016 Jan;63:262-70. doi: 10.1016/j.psyneuen.2015.10.007. Epub 2015 Oct 16.
Schizophrenia is a multifactorial disorder and environmental risk factors for it might contribute to hypothalamo-pituitary-adrenal axis (HPA) dysregulation. While increased cortisol levels have been reported in schizophrenia, as well as in early psychosis (compared to healthy controls), a crucial unresolved issue is whether elevated cortisol levels could be related to the distress of an emerging illness, rather than being specific to psychosis. Here, we report new findings from the first French cohort of young help-seekers (ICAAR) including ultra-high risk subjects (UHR), first-episode of psychosis (FEP) and non at-risk help seekers controls (HSC), followed by a meta-analysis of all available reports on salivary basal cortisol levels in early psychosis (UHR and FEP).
In the ICAAR study, 169 individuals (15-30 years old) had their basal cortisol levels sampled and they were categorized (at baseline) as either UHR, FEP, or HSC using the criteria of the Comprehensive Assessment of At-Risk Mental States (CAARMS). The three groups were compared at baseline, and the UHR and HSC individuals were also included in a one-year longitudinal follow-up. UHRs who converted to psychosis at the follow up (UHR-P) were compared to non-converters (UHR-NP). We also performed a meta-analysis from case-control studies with basal salivary measures of cortisol, drawing from a systematic bibliographic search using the keywords 'cortisol', 'glucocorticoid', 'HPA' with 'UHR', 'CHR', 'at-risk mental state', 'schizotypal ', 'prodromal schizophrenia', 'first-episode psychosis', 'first episode schizophrenia', 'newly diagnosed schizophrenia', 'recent onset schizophrenia' [in Medline, Web of Knowledge (WOS), EBSCO], followed by a systematic screening of the resulting articles.
Basal cortisol levels were not significantly different between UHR, FEP, and HSC controls in the ICAAR cohort. Interestingly, initial cortisol levels were correlated with positive symptoms at the one year follow-up in the ICAAR cohort. The meta-analysis revealed a significant elevation of the salivary basal cortisol levels in UHR individuals compared to controls (8 studies--1060 individuals), but not between FEP and controls (6 studies--441 individuals). Indirect comparison of salivary basal cortisol levels between UHR and FEP did not yield significant differences. Finally, no differences were detected between the baseline cortisol of UHR-P and UHR-NP (4 studies--301 individuals).
The meta-analysis (including new data) indicates that basal cortisol levels were increased in UHR compared to controls, but FEP levels were not different from UHR or controls. Many confounding factors could decrease the effect size in FEP especially medication intake. Taken together with our new results (which made use of help-seeker controls, and not merely healthy controls), the findings indicate that basal cortisol levels may not be a reliable biomarker for early psychosis. Further studies are needed to clarify the precise role of the HPA axis in psychotic conversion.
精神分裂症是一种多因素疾病,其环境危险因素可能导致下丘脑 - 垂体 - 肾上腺轴(HPA轴)功能失调。虽然已有报道称精神分裂症患者以及早期精神病患者(与健康对照相比)的皮质醇水平升高,但一个关键的未解决问题是,皮质醇水平升高是否与新发疾病的痛苦有关,而非精神病所特有。在此,我们报告了法国首个年轻求助者队列(ICAAR)的新发现,该队列包括超高风险受试者(UHR)、精神病首发患者(FEP)和非风险求助者对照(HSC),随后对早期精神病(UHR和FEP)唾液基础皮质醇水平的所有可用报告进行了荟萃分析。
在ICAAR研究中,169名年龄在15至30岁之间的个体进行了基础皮质醇水平采样,并使用高危精神状态综合评估(CAARMS)标准在基线时将他们分类为UHR、FEP或HSC。在基线时对三组进行比较,UHR和HSC个体还纳入了为期一年的纵向随访。将随访时转为精神病的UHR(UHR - P)与未转换者(UHR - NP)进行比较。我们还对使用皮质醇唾液基础测量的病例对照研究进行了荟萃分析,通过使用关键词“皮质醇”、“糖皮质激素”、“HPA轴”以及“UHR”、“CHR”、“高危精神状态”、“分裂型人格”、“前驱精神分裂症”、“精神病首发”、“精神分裂症首发”、“新诊断精神分裂症”、“近期起病精神分裂症”[在医学在线(Medline)、科学网(Web of Knowledge,WOS)、EBSCO数据库中]进行系统的文献检索,随后对所得文章进行系统筛选。
在ICAAR队列中,UHR、FEP和HSC对照之间的基础皮质醇水平无显著差异。有趣的是,在ICAAR队列中,初始皮质醇水平与一年随访时的阳性症状相关。荟萃分析显示,与对照相比,UHR个体的唾液基础皮质醇水平显著升高(8项研究 - 1060名个体),但FEP与对照之间无显著差异(6项研究 - 441名个体)。UHR和FEP之间唾液基础皮质醇水平的间接比较未发现显著差异。最后,UHR - P和UHR - NP的基线皮质醇水平之间未检测到差异(4项研究 - 301名个体)。
荟萃分析(包括新数据)表明,与对照相比,UHR的基础皮质醇水平升高,但FEP水平与UHR或对照无差异。许多混杂因素可能会降低FEP中的效应量,尤其是药物摄入。结合我们的新结果(使用求助者对照,而不仅仅是健康对照),这些发现表明基础皮质醇水平可能不是早期精神病的可靠生物标志物。需要进一步研究以阐明HPA轴在精神病转化中的精确作用。